Skip to main content
SpringerLink
Log in

Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Chest pain is one of the most common complaints seen in emergency departments (ED), up to 5–8 % of all ED visits. About 50–60 % of chest pain patients presenting to the ED are hospitalized. Seventy percentage of those patients not discharged from the ED are subsequently shown to not have acute cardiac disease. It has been estimated that emergency physician miss 2–6 % of acute coronary syndrome (ACS) that present to ED. While admitting a non-ACS patient is a financial burden on the medical system, releasing to home an undiagnosed ACS patient has life-threatening consequences. This study used flow cytometry to evaluate a panel of mononuclear cells, neutrophils, cytokines and fibrinolytic activation markers in patients presenting in ED with acute chest pain. The goal was to add diagnostic tools to the differentiation between true ischemic cardiac and non-ischemic chest pain in the process of triage. The study population consisted of 74 consecutive patients presenting with acute chest pain to the emergency department of Ziv Medical Center and were admitted to Intensive Cardiac Care Unit or Internal Wards of our hospital during the period September 2009 to February 2010. ACS has been clearly associated with a decrease in CD89+/CD62L+ population, an increase in percentage of cytotoxic T-cell subset, and an increase in platelet marker. Differences in thrombin receptor surface expression were also noted. The combination of multiple biomarkers may help to enhance diagnostic accuracy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Goldman L, Cook EF, Johnson PA, Brand DA, Rouan GW, Lee TH (1996) Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain. N Engl J Med 334(23):1498–1504

    Article  PubMed  CAS  Google Scholar 

  2. Kontos MC, Jesse RL (2000) Evaluation of the emergency department chest pain patient. Am J Cardiol 85:32B–39B

    Article  PubMed  CAS  Google Scholar 

  3. Christenson J, Innes G, McKnight D, Boychuk B, Grafstein E, Thompson CR, Rosenberg F, Anis AH, Gin K, Tilley J, Wong H, Singer J (2004) Safety and efficiency of emergency department assessment of chest discomfort. CMAJ 170(12):1803–1807

    Article  PubMed  Google Scholar 

  4. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH, Heiss G (1998) Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339(13):861–867

    Article  PubMed  CAS  Google Scholar 

  5. Reilly BM, Evans AT, Schaider JJ, Wang Y (2002) Triage of patients with chest pain in the emergency department: a comparative study of physicians’ decisions. Am J Med 112(2):95–103

    Article  PubMed  Google Scholar 

  6. Blum A, Sclarovsky S, Rehavia E, Shohat B (1994) Levels of T-lymphocyte subpopulations, interleukin-1 beta, and soluble interleukin-2 receptor in acute myocardial infarction. Am Heart J 127(5):1226–1230. doi:0002-8703(94)90040-X

    Article  PubMed  CAS  Google Scholar 

  7. Blum A, Yeganeh S (2003) The role of T-lymphocyte subpopulations in acute myocardial infarction. Eur J Intern Med 14(7):407–410

    Article  PubMed  CAS  Google Scholar 

  8. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL 3rd, Goldberg RJ, Michelson AD (2001) Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 38(4):1002–1006

    Article  PubMed  CAS  Google Scholar 

  9. Michelson A, Newburger P (2007) Platelets and Leukocytes: aggregate knowledge. Blood 110(3):794–795

    Article  CAS  Google Scholar 

  10. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104(13):1533–1537

    Article  PubMed  CAS  Google Scholar 

  11. Libby P (2001) Current concepts in the pathogenesis of the acute coronary syndromes. Circulation 104:365–372

    Article  PubMed  CAS  Google Scholar 

  12. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111:3481–3488

    Article  PubMed  Google Scholar 

  13. Viles-Gonzalez JF, Fuster V, Badimon JJ (2004) Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J 25(14):1197–1207

    Article  PubMed  CAS  Google Scholar 

  14. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331(7):417–424

    Article  PubMed  CAS  Google Scholar 

  15. Ridker PM (2003) Clinical application of CRP for cardiovascular disease detection and prevention. Circulation 107(3):363–369

    Article  PubMed  Google Scholar 

  16. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R (2001) Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has role in plague progression. Circulation 103:934–940

    Article  PubMed  CAS  Google Scholar 

  17. Davies MJ (1996) Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 94(8):2013–2020

    Article  PubMed  CAS  Google Scholar 

  18. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86(2):515–581

    Article  PubMed  CAS  Google Scholar 

  19. Zaman AG, Helft G, Worthley SG, Badimon JJ (2000) The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 149(2):251–266

    Article  PubMed  CAS  Google Scholar 

  20. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ, Rimm EB (2004) Inflammatory markers and the risk coronary heart disease in men and women. N Engl J Med 351(25):2599–2610

    Article  PubMed  CAS  Google Scholar 

  21. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE (2001) Elevated plasma levels of IL-2 in ischemic heart disease. Clin Cardiol 24(3):253–256

    Article  PubMed  CAS  Google Scholar 

  22. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML (2003) Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 348(12):1104–1111. doi:10.1056/NEJMoa022600

    Article  PubMed  CAS  Google Scholar 

  23. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM (2003) Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107(16):2109–2114. doi:10.1161/01.CIR.0000065232.57371.25

    Article  PubMed  CAS  Google Scholar 

  24. Aragam KG, Bhatt DL (2011) Antiplatelet therapy in acute coronary syndromes. J Cardiovasc Pharmacol Ther 16(1):24–42

    Article  PubMed  CAS  Google Scholar 

  25. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW (2012) Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med 366(1):20–33. doi:10.1056/NEJMoa1109719

    Article  PubMed  CAS  Google Scholar 

  26. Figueras J, Monasterio Y, Lidón RM, Nieto E, Soler–Soler J (2000) Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. J Am Coll Cardiol 36(7):2036–2043

    Article  PubMed  CAS  Google Scholar 

  27. Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK (2001) Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 21:611–617

    Article  PubMed  CAS  Google Scholar 

  28. Gram J, Bladbjerg EM, Møller L, Sjøl A, Jespersen J (2000) Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. J Intern Med 247:205–212

    Article  PubMed  CAS  Google Scholar 

  29. Humsten A, de Faire U, Walldius G, Dahlén G, Szamosi A, Landou C, Blombäck M, Wiman B (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2:3–9

    Article  Google Scholar 

  30. Nadir Y, Katz T, Sarig G, Hoffman R, Oliven A, Rowe JM, Brenner B (2005) Hemostatic balance on the surface of leukemic cells: the role of tissue factor and urokinase plasminogen activator receptor. Haematologica 90(11):1549–1556

    PubMed  CAS  Google Scholar 

  31. Panasiuk A, Zak J, Panasiuk B, Prokopowicz D (2007) Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis. Blood Coagul Fibrinolysis 18(8):739–744. doi:10.1097/MBC.0b013e3282ef99f600001721-200712000-00005

    Article  PubMed  CAS  Google Scholar 

  32. Plesner T, Behrendt N, Ploug M (1997) Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 15(6):398–408. doi:10.1002/stem.150398

    Article  PubMed  CAS  Google Scholar 

  33. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S (1997) Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 134((2 Pt 1)):253–259

    Article  PubMed  CAS  Google Scholar 

  34. Bodi V, Sanchis J, Nunez J, Mainar L, Minana G, Benet I, Solano C, Chorro FJ, Llacer A (2008) Uncontrolled immune response in acute myocardial infarction: unraveling the thread. Am Heart J 156(6):1065–1073. doi:10.1016/j.ahj.2008.07.008

    Article  PubMed  CAS  Google Scholar 

  35. Pasqui AL, Di Renzo M, Bova G, Bruni F, Puccetti L, Pompella G, Auteri A (2003) T cell activation and enhanced apoptosis in non-ST elevation myocardial infarction. Clin Exp Med 3(1):37–44. doi:10.1007/s102380300014

    Article  PubMed  CAS  Google Scholar 

  36. von Haehling S, Schefold JC, Jankowska E, Doehner W, Springer J, Strohschein K, Genth-Zotz S, Volk HD, Poole-Wilson P, Anker SD (2009) Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure. PLoS ONE 4(7):1–7

    Google Scholar 

  37. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L (2005) Circulating levels of proinflammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 95:452–456

    Article  PubMed  CAS  Google Scholar 

  38. May AE, Schmidt R, Kanse SM, Chavakis T, Stephens RW, Schomig A, Preissner KT, Neumann FJ (2002) Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood 100(10):3611–3617. doi:10.1182/blood-2002-03-0778

    Article  PubMed  CAS  Google Scholar 

  39. Michelson AD, Linden MD, Barnard MR, Furman MI, Frelinger AL (2007) Flow cytometry. In: Michelson AD (ed) Platelets, 2nd edn. Elsevier/Academic Press, San Diego, pp 545–564

    Chapter  Google Scholar 

  40. Kofler S, Sisic Z, Shvets N, Lohse P, Weis M (2011) Expression of circulatory dendritic cells and regulatory T-cells in patients with different subsets of coronary artery disease. J Cardiovasc Pharmacol 57(5):542–549. doi:10.1097/FJC.0b013e3182124c53

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Institute, Ziv Medical Center Safed, 13100, Safed, Israel

    Tatyana Levinas & Alon Marmur

  2. Hematology Institute, Ziv Medical Center Safed, 13100, Safed, Israel

    Elizabeth Eshel & Najib Dally

  3. Research Institute, Ziv Medical Center Safed, 13100, Safed, Israel

    Adi Sharabi-Nov

  4. Flow Cytometry Unit, Ziv Medical Center Safed, 13100, Safed, Israel

    Elizabeth Eshel

Authors
  1. Tatyana Levinas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Eshel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adi Sharabi-Nov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alon Marmur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Najib Dally
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Eshel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levinas, T., Eshel, E., Sharabi-Nov, A. et al. Differentiating ischemic from non-ischemic chest pain using white blood cell-surface inflammatory and coagulation markers. J Thromb Thrombolysis 34, 235–243 (2012). https://doi.org/10.1007/s11239-012-0707-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0707-9

Keywords

Search

Navigation